1029 related articles for article (PubMed ID: 16883934)
1. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
Mańkowska A; Rejdak R; Nowomiejska K; Zagórski Z
Klin Oczna; 2006; 108(1-3):24-7. PubMed ID: 16883934
[TBL] [Abstract][Full Text] [Related]
2. Triamcinolone acetonide facilitates removal of the epiretinal membrane and separation of the residual vitreous cortex in highly myopic eyes with retinal detachment due to a macular hole.
Yamamoto N; Ozaki N; Murakami K
Ophthalmologica; 2004; 218(4):248-56. PubMed ID: 15258413
[TBL] [Abstract][Full Text] [Related]
3. Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removal: ultrastructural analysis of the inner limiting membrane.
Matsumoto H; Yamanaka I; Hisatomi T; Enaida H; Ueno A; Hata Y; Sakamoto T; Ogino N; Ishibashi T
Retina; 2007 Feb; 27(2):174-9. PubMed ID: 17290199
[TBL] [Abstract][Full Text] [Related]
4. Double visualization using triamcinolone acetonide and trypan blue during stage 3 macular hole surgery.
Yamamoto N; Ozaki N; Murakami K
Ophthalmologica; 2004; 218(5):297-305. PubMed ID: 15334009
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling.
Kumagai K; Furukawa M; Ogino N; Larson E; Uemura A
Retina; 2007; 27(9):1249-54. PubMed ID: 18046233
[TBL] [Abstract][Full Text] [Related]
6. [Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonide].
Mańkowska A; Rejdak R; Oleszczuk A; Kiczyńska M; Łekawa A; Choragiewicz T; Zagórski Z
Klin Oczna; 2008; 110(4-6):151-4. PubMed ID: 18655452
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy.
Dyer D; Callanan D; Bochow T; Abraham P; Lambert HM; Lee SY; Schneiderman T; Potts SL; Walker TM
Retina; 2009 Jan; 29(1):38-45. PubMed ID: 18827733
[TBL] [Abstract][Full Text] [Related]
8. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.
Sonoda KH; Sakamoto T; Enaida H; Miyazaki M; Noda Y; Nakamura T; Ueno A; Yokoyama M; Kubota T; Ishibashi T
Ophthalmology; 2004 Feb; 111(2):226-30. PubMed ID: 15019367
[TBL] [Abstract][Full Text] [Related]
9. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
10. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema.
Figueroa MS; Contreras I; Noval S
Retina; 2008 Mar; 28(3):420-6. PubMed ID: 18327133
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema.
Asami T; Terasaki H; Kachi S; Nakamura M; Yamamura K; Nabeshima T; Miyake Y
Ophthalmology; 2004 Feb; 111(2):231-7. PubMed ID: 15019368
[TBL] [Abstract][Full Text] [Related]
12. Internal limiting membrane peeling using triamcinolone acetonide: histopathologic confirmation.
Shah GK; Rosenblatt BJ; Smith M
Am J Ophthalmol; 2004 Oct; 138(4):656-7. PubMed ID: 15488800
[TBL] [Abstract][Full Text] [Related]
13. Safety of Triamcinolone acetonide (TA)-assisted pars plana vitrectomy in macular hole surgery.
Kampougeris G; Cheema R; McPherson R; Gorman C
Eye (Lond); 2007 May; 21(5):591-4. PubMed ID: 16456587
[TBL] [Abstract][Full Text] [Related]
14. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
16. Preventing the deposition of triamcinolone in macular hole by use of whole blood in triamcinolone-assisted membrane peeling.
Lai CC; Chuang LH; Wang NK; Yeung L; Chen YP; Hwang YS; Chen KJ; Wu WC
Retina; 2007 Sep; 27(7):932-7. PubMed ID: 17891019
[TBL] [Abstract][Full Text] [Related]
17. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Yamashita T; Uemura A; Kita H; Sakamoto T
J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up results of ilm peeling during vitrectomy surgery for premacular fibrosis.
Schadlu R; Tehrani S; Shah GK; Prasad AG
Retina; 2008 Jun; 28(6):853-7. PubMed ID: 18536602
[TBL] [Abstract][Full Text] [Related]
19. Triamcinolone acetonide-assisted peeling of the internal limiting membrane.
Kimura H; Kuroda S; Nagata M
Am J Ophthalmol; 2004 Jan; 137(1):172-3. PubMed ID: 14700661
[TBL] [Abstract][Full Text] [Related]
20. Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy.
Yamakiri K; Sakamoto T; Noda Y; Nakahara M; Ogino N; Kubota T; Yokoyama M; Furukawa M; Sonoda Y; Yamada T; Doi N; Enaida H; Hata Y; Ishibashi T
Ophthalmology; 2007 Feb; 114(2):289-96. PubMed ID: 17270679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
